Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1.39B
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
43.6M
-
Shares change
-
-2.83M
-
Total reported value, excl. options
-
$8.06B
-
Value change
-
-$556M
-
Put/Call ratio
-
0.82
-
Number of buys
-
104
-
Number of sells
-
-103
-
Price
-
$184.71
Significant Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q4 2024
267 filings reported holding ONC - BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share as of Q4 2024.
BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) has 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.6M shares
of 1.39B outstanding shares and own 3.15% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (9.53M shares), Capital International Investors (6.11M shares), PRIMECAP MANAGEMENT CO/CA/ (5.1M shares), HHLR ADVISORS, LTD. (3.8M shares), BAILLIE GIFFORD & CO (3.67M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.94M shares), FMR LLC (1.85M shares), Temasek Holdings (Private) Ltd (1.53M shares), MORGAN STANLEY (738K shares), and BlackRock, Inc. (734K shares).
This table shows the top 220 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.